TMS Related Biomarker Assessments

Completed · Not applicable · Has a placebo group

Conditions studied: Schizophrenia Schizoaffective, Schizophrenia

In brief

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active and sham repetitive transcranial magnetic stimulation (rTMS) in separate sessions. SSD-related biomarkers will be assessed before and after the rTMS administration.

Key facts

Study ID
NCT05660018
Run by
University of Maryland, Baltimore
People needed
10
Starts
2023-01-07
Expected to finish
2025-02-14
Last updated by the study team
2026-01-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.